Clinical Trials List
2023-07-01 - 2026-01-31
Phase III
Recruiting7
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Po-Tseng Lee Division of Cardiovascular Diseases
- 陳柏偉 Division of Cardiovascular Diseases
- 李文煌 Division of Cardiovascular Diseases
- Po-Sheng Chen Division of Cardiovascular Diseases
- 張獻元 Division of Cardiovascular Diseases
- 黃鼎鈞 Division of Cardiovascular Diseases
- 柯呈諭 Division of Cardiovascular Diseases
- 黃睦翔 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Ming Shih Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
- Yung-Ta Kao Division of Cardiovascular Diseases
- 詹超舜 Division of Cardiovascular Diseases
- Tsung-Lin Yang Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEI-TIEN CHANG Division of Emergency Medicine
- MAO-HSIN LIN Division of General Internal Medicine
- JEN-KUANG LEE Division of General Internal Medicine
- 江君揚 Division of General Internal Medicine
- 王植賢 Division of General Surgery
- CHIEN-HUA HUANG Division of Emergency Medicine
- 陳盈憲 Division of General Internal Medicine
- 柯宗佑 Division of General Internal Medicine
- 賀立婷 Division of General Internal Medicine
- LIAN-YU LIN Division of General Internal Medicine
- 楊鎧鍵 Division of General Internal Medicine
- Hsien Li Kao Division of General Internal Medicine
- YEN-HUNG LIN Division of General Internal Medicine
- Chih-Fan Yeh Division of General Internal Medicine
- 林柏志 Division of General Internal Medicine
- 鄭人方 Division of General Internal Medicine
- Chau-Chung Wu Division of General Internal Medicine
- Tzung-Dau Wang Division of General Internal Medicine
- 黃慶昌 Division of General Internal Medicine
- CHO-KAI WU Division of General Internal Medicine
- 蔡承烜 Division of General Internal Medicine
- Yi-Chih Wang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 洪俊聲 Division of Cardiovascular Diseases
- 黃柏森 Division of Cardiovascular Diseases
- 周銘霆 Division of Cardiovascular Diseases
- Zhih-Cherng Chen Division of Cardiovascular Diseases
- Chia-Te Liao Division of Cardiovascular Diseases
- 蔣俊彥 Division of Cardiovascular Diseases
- 李威杰 Division of Cardiovascular Diseases
- 張瑋婷 Division of Cardiovascular Diseases
- 黃聖中 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
165 participants
-
Global
2760 participants
